Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog

A slow-release formulation of the luteinizing hormone releasing hormone (LH-RH)analog(TAP-144-SR) was administered in 6 cases of prostatic cancer. Five were untreated cases, 3 of moderately-differentiated and 2 of poorly-differentiated cancers (four D2 and one C, NX), the other (D2) was under contro...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 34(1988), 3 vom: 15. März, Seite 555-60
1. Verfasser: Fuse, H (VerfasserIn)
Weitere Verfasser: Akimoto, S, Akakura, K, Shimazaki, J, Murakami, S
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1988
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Antineoplastic Agents Delayed-Action Preparations Gonadotropin-Releasing Hormone 33515-09-2 Testosterone 3XMK78S47O Luteinizing Hormone 9002-67-9 mehr... Follicle Stimulating Hormone 9002-68-0 Acid Phosphatase EC 3.1.3.2 Leuprolide EFY6W0M8TG